Download presentation
Presentation is loading. Please wait.
Published byPhan Đặng Modified over 5 years ago
1
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation Xiao-Jun Huang, Dai-Hong Liu, Kai-Yan Liu, Lan-Ping Xu, Huan Chen, Wei Han, Yu-Hong Chen, Xiao-Hui Zhang, Dao-Pei Lu Biology of Blood and Marrow Transplantation Volume 15, Issue 2, Pages (February 2009) DOI: /j.bbmt Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Incidence of total aGVHD and severe aGVHD after HLA-mismatched/haploidentical HSCT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 Incidence of cGVHD and extensive cGVHD after HLA/mismatched/haploidentical HSCT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
4
Figure 3 (a) Relapse of patients with AML after HLA-mismatched/haploidentical HSCT. (b) Relapse of patients with ALL after HLA-mismatched/haploidentical HSCT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
5
Figure 4 (a) LFS of patients with AML after HLA-mismatched/haploidentical HSCT. (b) LFS of patients with ALL after HLA-mismatched/haploidentical HSCT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
6
Figure 5 (a) OS of patients with AML after HLA-mismatched/haploidentical HSCT. (b) OS of patients with ALL after HLA-mismatched/haploidentical HSCT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.